Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 8, 2013, Pages 3011-3016

  Pang, Wendy W ^a   Pluvinage, John V ^a   Price, Elizabeth A ^a   Sridhar, Kunju ^a   Arber, Daniel A ^a   Greenberg, Peter L ^a   Schrier, Stanley L ^a   Park, Christopher Y ^b   Weissman, Irving L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Aging; Blood disorders; Cancer stem cell; Monosomy 7; Myelodysplasia

Indexed keywords

CALRETICULIN; CD47 ANTIGEN; THY 1 ANTIGEN;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BONE MARROW; CANCER PATIENT; CELL POPULATION; COLONY FORMING UNIT GM; CONTROLLED STUDY; CYTOPENIA; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOPHENOTYPING; LOW RISK POPULATION; MONOSOMY 7; MOUSE; MYELODYSPLASTIC SYNDROME; MYELOID PROGENITOR CELL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REFRACTORY ANEMIA WITH EXCESS BLASTS; UPREGULATION;

ANIMALS; ANTIGENS, CD; HEMATOPOIETIC STEM CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICE; MYELODYSPLASTIC SYNDROMES; PHAGOCYTOSIS;

EID: 84874235360     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1222861110     Document Type: Article

References (43)

1. Brunning R, et al. (2008) Myelodysplastic syndromes/neoplasms. WHO Classification of Tumours and Haematopoietic and Lymphoid Tissues, eds Swerdlow S, et al. (Intl Agency Res Cancer, Lyon, France), Vol 2.
2. Hofmann WK, Koeffler HP (2005) Myelodysplastic syndrome. Annu Rev Med 56:1-16.
3. Greenberg P, et al. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89 (6):2079-2088.
4. Greenberg PL, et al. (2012) Revised international prognostic scoring system for mye-lodysplastic syndromes. Blood 120 (12):2454-2465.
5. van de Loosdrecht AA, et al. (2009) Standardization of flow cytometry in myelodys-plastic syndromes: Report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes. Haematologica 94 (8):1124-1134.
6. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B (1992) Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 89 (7):2804-2808.
7. Uchida N, et al. (1998) HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proc Natl Acad Sci USA 95 (20):11939-11944.
8. Manz MG, Miyamoto T, Akashi K, Weissman IL (2002) Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci USA 99 (18):11872-11877.
9. Majeti R, Park CY, Weissman IL (2007) Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell 1 (6):635-645.
10. Nilsson L, et al. (2002) Involvement and functional impairment of the CD34 (+) CD38 (-) Thy-1 (+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8. Blood 100 (1):259-267.
11. Nilsson L, et al. (2007) The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes. Blood 110 (8):3005-3014.
12. Tehranchi R, et al. (2010) Persistent malignant stem cells in del (5q) myelodysplasia in remission. N Engl J Med 363 (11):1025-1037.
13. Will B, et al. (2012) Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations. Blood 120 (10):2076-2086.
14. Raza A, et al. (1997) Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo-and/or bromodeoxyuridine. Exp Hematol 25 (6):530-535.
15. Mundle SD, et al. (1996) Indication of an involvement of interleukin-1 beta converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromes. Blood 88 (7):2640-2647.
16. Shetty V, et al. (1996) Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leuk Res 20 (11-12):891-900.
17. Rajapaksa R, Ginzton N, Rott LS, Greenberg PL (1996) Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells. Blood 88 (11):4275-4287.
18. Chao MP, et al. (2010) Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47. Sci Transl Med 2 (63):63ra94.
19. Gardai SJ, et al. (2005) Cell-surface calreticulin initiates clearance of viable or apo-ptotic cells through trans-activation of LRP on the phagocyte. Cell 123 (2):321-334.
20. Orr AW, et al. (2003) Low density lipoprotein receptor-related protein is a calreticulin coreceptor that signals focal adhesion disassembly. J Cell Biol 161 (6):1179-1189.
21. Jaiswal S, et al. (2009) CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 138 (2):271-285.
22. Chan KS, et al. (2009) Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc Natl Acad Sci USA 106 (33):14016-14021.
23. Chao MP, et al. (2010) Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell 142 (5):699-713.
24. Chao MP, et al. (2011) Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia. Cancer Res 71 (4):1374-1384.
25. Bhatia M, Wang JC, Kapp U, Bonnet D, Dick JE (1997) Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA 94 (10):5320-5325.
26. Péault B, Weissman IL, Buckle AM, Tsukamoto A, Baum C (1993) Thy-1-expressing CD34+ human cells express multiple hematopoietic potentialities in vitro and in SCID-hu mice. Nouv Rev Fr Hematol 35 (1):91-93.
27. McCune JM, et al. (1988) The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 241 (4873):1632-1639.
28. Negrin RS, et al. (2000) Transplantation of highly purified CD34+Thy-1+ hemato-poietic stem cells in patients with metastatic breast cancer. Biol Blood Marrow Transplant 6 (3):262-271.
29. Murray L, et al. (1994) Analysis of human hematopoietic stem cell populations. Blood Cells 20 (2-3):364-369, discussion369-370.
30. Pang WW, et al. (2011) Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci USA 108 (50):20012-20017.
31. Park CY, Majeti R, Weissman IL (2008) In vivo evaluation of human hematopoiesis through xenotransplantation of purified hematopoietic stem cells from umbilical cord blood. Nat Protoc 3 (12):1932-1940.
32. Jamieson CH, et al. (2004) Granulocyte-macrophage progenitors as candidate leuke-mic stem cells in blast-crisis CML. N Engl J Med 351 (7):657-667.
33. Sternberg A, et al. (2005) Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome. Blood 106 (9):2982-2991.
34. Miyamoto T, Weissman IL, Akashi K (2000) AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci USA 97 (13):7521-7526.
35. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414 (6859):105-111.
36. Weissman I (2005) Stem cell research: Paths to cancer therapies and regenerative medicine. JAMA 294 (11):1359-1366.
37. Chao MP, Majeti R, Weissman IL (2012) Programmed cell removal: A new obstacle in the road to developing cancer. Nat Rev Cancer 12 (1):58-67.
38. Jamieson CH, et al. (2006) The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. Proc Natl Acad Sci USA 103 (16):6224-6229.
39. Rossi DJ, Jamieson CH, Weissman IL (2008) Stems cells and the pathways to aging and cancer. Cell 132 (4):681-696.
40. Abrahamsson AE, et al. (2009) Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation. Proc Natl Acad Sci USA 106 (10):3925-3929.
41. Jan M, et al. (2012) Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Sci Transl Med 4 (149):149ra118.
42. Lagasse E, Weissman IL (1994) bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J Exp Med 179 (3):1047-1052.
43. Ishikawa F, et al. (2005) Development of functional human blood and immune systems in NOD/SCID/IL2 receptor gamma chain (null) mice. Blood 106 (5):1565-1573.